Document Detail


Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans.
MedLine Citation:
PMID:  1574976     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The potent inflammatory mediator PAF-acether (PAF = platelet-activating factor) can produce the same hemodynamic and hematological effects as protamine infusion. In 10 patients, blood PAF and precursor levels were measured in the left atrium, the pulmonary and the radial artery before and after protamine reversal of heparin during coronary artery bypass graft. Blood PAF level in the left atrium increased 6-fold (17 +/- 12 pg.ml-1 vs 98 +/- 46 pg.ml-1, P = 0.03) after protamine infusion. By contrast, a 4-fold decrease was observed in the pulmonary artery blood (130 +/- 48 pg.ml-1 vs 31 +/- 23 pg.ml-1, P = 0.03) and a 9-fold decrease was noted in the radial artery blood (285 +/- 104 pg.ml-1 vs 31 +/- 15 pg.ml-1, P = 0.01). No cardiovascular impairment was observed but all patients exhibited thrombocytopenia. After protamine, PAF in the left atrium reached lower levels than those observed in the pulmonary and radial artery before protamine infusion. Moreover, no significant correlation was observed between platelet counts and PAF levels. Thus PAF seems not to mediate the platelet drop induced by heparin-protamine complexes. A positive correlation was obtained between leukocyte counts in the pulmonary artery and PAF levels in the left atrium (r = 0.78, P = 0.02). Protamine infusion may stimulate PAF biosynthesis by leukocytes in the lung, on the one hand, and accelerate the disappearance of PAF in the arterial bed, on the other hand.
Authors:
N Nathan; Y Denizot; P Feiss; E Cornu; J Benveniste; B Arnoux
Related Documents :
12779256 - Variability in the vascularity of the pectoralis major muscle.
21990456 - Unusual thromboembolic complication during an anterior communicating artery aneurysm co...
21932486 - Leptospirosis induced pulmonary alveolar hemorrhage.
14615916 - Collateral arterial pathways in the forearm.
8678336 - Bilateral internal carotid artery disease secondary to cervical radiation. a case report.
9555856 - Ultrastructural localization of secretory type ii phospholipase a2 in atherosclerotic a...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta anaesthesiologica Scandinavica     Volume:  36     ISSN:  0001-5172     ISO Abbreviation:  Acta Anaesthesiol Scand     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-06-04     Completed Date:  1992-06-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370270     Medline TA:  Acta Anaesthesiol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  264-9     Citation Subset:  IM    
Affiliation:
Department of Anaesthesiology, CHU Dupuytren, Limoges, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Artery Bypass*
Female
Hemodynamics / physiology
Heparin Antagonists / pharmacology*
Humans
Male
Middle Aged
Platelet Activating Factor / analogs & derivatives,  analysis*
Protamines / pharmacology*
Chemical
Reg. No./Substance:
0/Heparin Antagonists; 0/O-deacetyl platelet activating factor; 0/Platelet Activating Factor; 0/Protamines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interaction of ORG 9426 and some of the clinically used intravenous anaesthetic agents in the cat.
Next Document:  Psychomotor recovery following propofol or isoflurane anaesthesia for day-care surgery.